Scott A Tomlins
Adjunct Associate Professor of Pathology
Adjunct Associate Professor of Urology
[email protected]

Available to mentor
Scott A Tomlins
Adjunct Associate Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Taubman Institute
    • Center Member
      Center for Computational Medicine and Bioinformatics
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Development and validation of a tumor tissue based multivariate biomarker for predicting angiogenesis inhibitor clinical benefit in renal cell carcinoma (RCC).
      Thomas SP, Vaishampayan UN, Johnson B, Lamb LE, Mowers J, Bulen BJ, Khazanov NA, Hovelson DH, Kwiatkowski K, Rhodes DR, Tomlins SA. Journal of Clinical Oncology, 2024 Feb 1; 42 (4_suppl): 467 - 467. DOI:10.1200/jco.2024.42.4_suppl.467
    • Journal Article
      P1.21-11 Immunotherapy Response Score (IRS) Predicts Pembrolizumab Clinical Benefit in Patients with NSCLC in TPS≥50%
      Suga J, Thomas S, Achacoso N, Jiang C, Chung E, Solorzano-Pinto A, Tse P, Bulen BJ, Khazanov NA, Lamb LE, Hovelson DH, Kwiatkowski K, Johnson DB, Rhodes DR, Tomlins SA, Habel LA. Journal of Thoracic Oncology, 2023 Nov; 18 (11): s238 - s239. DOI:10.1016/j.jtho.2023.09.397
    • Journal Article
      MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.
      Tosoian JJ, Sessine MS, Trock BJ, Ross AE, Xie C, Zheng Y, Samora NL, Siddiqui J, Niknafs Y, Chopra Z, Tomlins S, Kunju LP, Palapattu GS, Morgan TM, Wei JT, Salami SS, Chinnaiyan AM. Prostate Cancer Prostatic Dis, 2023 Sep; 26 (3): 563 - 567. DOI:10.1038/s41391-022-00633-3
      PMID: 36585434
    • Presentation
      Translating the Cancer Genome & Transcriptome to the Clinic
      Tomlins S. 2023 Aug 10;
    • Journal Article
      Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
      Bulen BJ, Khazanov NA, Hovelson DH, Lamb LE, Matrana M, Burkard ME, Yang ES-H, Edenfield WJ, Claire Dees E, Onitilo AA, Buchschacher GL, Miller AM, Parsons BM, Wassenaar TR, Suga JM, Siegel RD, Irvin W, Nair S, Slim JN, Misleh J, Khatri J, Masters GA, Thomas S, Safa MM, Anderson DM, Mowers J, Dusenbery AC, Drewery S, Plouffe K, Reeder T, Vakil H, Patrias L, Falzetta A, Hamilton R, Kwiatkowski K, Johnson DB, Rhodes DR, Tomlins SA. Cancer Res Commun, 2023 Jul; 3 (7): 1335 - 1349. DOI:10.1158/2767-9764.CRC-23-0036
      PMID: 37497337
    • Journal Article
      Differentiating bladder cancer (BLCA) tumor immune microenvironment (TME) profiles based on predicted intrinsic radiosensitivity (RS).
      Vuong W, Ganguly S, Balyimez A, Halima A, Kerr C, Day ML, Tomlins SA, Grivas P, Gupta S, Chan TA-T, Jha B, Mian OY. Journal of Clinical Oncology, 2023 Jun 1; 41 (16_suppl): e16622 - e16622. DOI:10.1200/jco.2023.41.16_suppl.e16622
    • Journal Article
      Evaluation of immunotherapy response score (IRS) for predicting pembrolizumab (pembro) clinical benefit in patients (pts) with advanced solid tumors.
      Thomas SP, Achacoso N, Jiang C, Chung E, Solorzano-Pinto AV, Tse P, Bulen BJ, Khazanov NA, Lamb LE, Hovelston DH, Kwiatkowski K, Johnson DB, Rhodes DR, Tomlins SA, Suga JM, Habel LA. Journal of Clinical Oncology, 2023 Jun 1; 41 (16_suppl): e14646 - e14646. DOI:10.1200/jco.2023.41.16_suppl.e14646
    • Journal Article
      Highly Recurrent IDH1 Mutations in Prostate Cancer With Psammomatous Calcification.
      Mehra R, Shah T, Liu C-J, Plouffe KR, Wang X, Mannan R, Cao X, Chinnaiyan AM, Tomlins SA, Udager AM. Mod Pathol, 2023 Jun; 36 (6): 100146 DOI:10.1016/j.modpat.2023.100146
      PMID: 36828361